Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Mellanox Technologies, Ltd. (NASDAQ:MLNX), Extreme Networks, Inc (NASDAQ:EXTR), Fifth Street Finance Corp. (NASDAQ:FSC), Immunomedics, Inc. (NASDAQ:IMMU)
Mellanox Technologies, Ltd. (NASDAQ:MLNX) managed to keep its gain at 5.04% on above-normal volume of 1.59M shares. The stock settled at $41.89 after floating in a range of $41.to $42.27. Its latest price has reached market capitalization of $1.82 billion. Its 52-week range has been $33.69 to $111.38. Mellanox Technologies, Ltd. (Mellanox), incorporated in March 1999, is a fabless semiconductor company that produces and supplies high-performance interconnects products that facilitate efficient data transmission between servers, storage systems, communications infrastructure equipment and other embedded systems.
For How Long MLNX will fight for Profitability? Read This Trend Analysis report
Extreme Networks, Inc (NASDAQ:EXTR) traded down on a volume of 1.56 million, lower than its standard daily volume. Shares have dropped-0.58% to $5.17. Over the last twelve months, the stock has gained 54.33% and faced a worst price of $2.99. Extreme Networks, Inc. is a United States-based company that provides local area network (LAN) switching solutions.
Has EXTR Found The Bottom And Ready To Gain Momentum? Find Out Here
Fifth Street Finance Corp. (NASDAQ:FSC) settled -0.78% lower at $10.18 on below -normal volume of 1.56M shares during the last trading day. The stock has its 12-month high at $11.13 and 52-week low price was $9.66. It traded in a range of $10.15 to $10.27 during the last trading day Fifth Street Finance Corp. is a specialty finance company that lends to and invests in small and mid-sized companies in connection with investments by private equity sponsors.
Will FSC Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Immunomedics, Inc. (NASDAQ:IMMU) was down on high volume, trading at a volume of 1.56M versus its average daily volume of 1.16 million shares. At $7.03, the stock has attained market capitalization of 583.04 million. Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
Why Should Investors Buy IMMU After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)